Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children | Zendy

Gili Kenet | Zendy; Siegal Sadetzki | Zendy; Havi Murad | Zendy; U. Martinowitz | Zendy; Nurit Rosenberg | Zendy; Sanford N. Gitel | Zendy; Gideon Rechavi | Zendy; Aida Inbal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children

Author(s) -

Gili Kenet,

Siegal Sadetzki,

Havi Murad,

U. Martinowitz,

Nurit Rosenberg,

Sanford N. Gitel,

Gideon Rechavi,

Aida Inbal

Publication year - 2000

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.31.6.1283

Subject(s) - medicine , thrombophilia , prothrombin g20210a , factor v leiden , antithrombin , methylenetetrahydrofolate reductase , protein s , stroke (engine) , protein s deficiency , protein c , risk factor , protein c deficiency , gastroenterology , factor v , thrombosis , venous thrombosis , heparin , allele , gene , genetics , mechanical engineering , biology , engineering

The association between ischemic childhood stroke and thrombophilia has been debated. We studied the prevalence of thrombophilia risk factors in 65 unrelated children with ischemic stroke compared with 145 control subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research